TOB2, a protein integral to cell cycle regulation and apoptosis, is influenced by a variety of chemical compounds that modulate distinct signaling pathways. Forskolin, through its action of increasing cAMP levels, indirectly enhances the activity of TOB2 via PKA-mediated phosphorylation of transcription factors, playing a pivotal role in cell cycle regulation. (-)-Epigallocatechin Gallate, functioning as a kinase inhibitor, also indirectly promotes TOB2's anti-proliferative function by altering signaling pathways involved in cell growth and death. Similarly, the lipid signaling molecule D-erythro-Sphingosine-1-phosphate, and Thapsigargin, which elevates intracellular calcium levels, both contribute to the modulation of transcription factors and calcium-dependent pathways respectively, thereby enhancing TOB2's regulatory functions in cell cycle control and apoptosis. LY 294002 and Wortmannin, as inhibitors of PI3K, skew cellular signaling in a manner that supports TOB2's role in inhibiting cell proliferation and inducing apoptosis.
Further, the inhibition of MAPK signaling by compounds like SB 203580 and U0126 favors pathways that enhance TOB2's activity in cell cycle arrest and anti-proliferative processes. PD 98059, another MEK inhibitor, follows a similar mechanism, modulating pathways that augment TOB2's role in cell cycle regulation. Staurosporine, though a broad-spectrum kinase inhibitor, selectively activates pathways associated with TOB2 by lifting kinase-mediated restrictions on processes regulated by TOB2, such as cell cycle arrest and apoptosis. Additionally, A23187, by increasing intracellular calcium levels, activates calcium-dependent signaling pathways, further enhancing TOB2's role in cell cycle control and response to cellular stress. Collectively, these compounds, through their targeted modulation of cellular signaling, enhance the functional activities of TOB2 in regulating cell cycle progression and apoptosis, illustrating the intricate network of biochemical pathways that govern cell behavior.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels. Elevated cAMP activates PKA, which can phosphorylate transcription factors influencing TOB2 expression and activity, thereby enhancing its role in cell cycle regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
As a kinase inhibitor, it modulates signaling pathways involved in cell proliferation and apoptosis. This inhibition indirectly enhances TOB2 activity, promoting its anti-proliferative function. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Engages in lipid signaling pathways affecting cellular processes like proliferation and apoptosis. This signaling can modulate transcription factors to enhance the expression and function of TOB2 in cell cycle control. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a key regulator of cell growth and proliferation. This inhibition favors the activity of TOB2, particularly in regulating cell cycle progression and growth. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, shifting the signaling equilibrium and potentially favoring pathways that enhance TOB2's activity in cell cycle arrest and anti-proliferative processes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Elevates intracellular calcium levels, activating calcium-dependent signaling pathways. These pathways can enhance TOB2's activity, particularly in roles related to cell cycle control and apoptosis. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum protein kinase inhibitor that can selectively activate pathways involving TOB2 by reducing kinase-mediated inhibition on TOB2-regulated processes like cell cycle arrest and apoptosis. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium, activating calcium-dependent pathways. This elevation can enhance TOB2's activity in roles associated with cell cycle control and response to cellular stress. | ||||||